Consensus GeoVax Labs, Inc.

Equities

GOVX

US3736786068

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-21 pm EDT			5-day change	1st Jan Change
1.61 ^USD	-1.23%		-5.29%	-70.27%

May. 14	Transcript : GeoVax Labs, Inc., Q1 2024 Earnings Call, May 14, 2024
Mar. 28	GeoVax Labs, Inc. to Present Data on GEO-CM04S1, a Next Generation Covid-19 Vaccine, at the World Vaccine Congress	CI

Evolution of the average Target Price on GeoVax Labs, Inc.

Price target over the last 5 years

History of analyst recommendation changes

f820a80879c25e0b2.UP0SeYEKw7K_7VYTvlyaq8090eS4GMf7e0omS8p9ugM.CoorCrg7scHShhpU8ivv04RTuo7nbauyAgteBrwy9ToRrnAB0nq71cm0PQ~f4bd695e5c0df1c8a9b3ab91816a41b2

Analyst Recommendations on GeoVax Labs, Inc.

Noble Capital Starts GeoVax Labs at Outperform With $6 Price Target	23-05-08	MT
HC Wainwright Starts GeoVax Labs at Buy With $8 Price Target	22-10-26	MT
GEOVAX LABS : Maxim Starts Geovax Labs at Buy with $8 Price Target	20-11-19	MT